First-of-its-kind clinical trial will use reprogrammed adult stem cells to treat Parkinson’s
Researchers in Japan today announced the launch of a clinical trial to treat Parkinson’s disease with neurological material derived from…
Researchers in Japan today announced the launch of a clinical trial to treat Parkinson’s disease with neurological material derived from…
David G. Maloney, MD, PhD, medical director of immunotherapy at the Seattle Cancer Care Alliance and member of Fred Hutchinson…